NCT02466464

Microporous Polysaccharide Hemospheres Epistaxis

Use of Microporous Polysaccharide Hemospheres (MPH) in Management of Acute Epistaxis

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Emory University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare a new treatment for nosebleeds to the treatment that has been used for many years.

Detailed description

Nosebleeds are a common condition which affect many Americans every day.The standard treatment in this hospital for nosebleeds that do not resolve with squeezing the nose or nasal spray is to place a nasal packing (aka nasal tampon) into the nose. This is an effective treatment in most cases, but patients may find it to be uncomfortable. The investigators will be comparing the standard nasal packing with a new type of powder which may also stop nosebleeds.

Conditions

• Epistaxis

Interventions

Type	Name	Description
DEVICE	Microporous Polysaccharide Hemospheres	Two grams of Arista powder will be placed into the nose followed by four minutes of pressure and a moustache dressing.
DEVICE	Nasal Tampon	8 cm of Merocel dressing will be placed into one or both sides of your nose for the next three to five days and will then be removed by the physician.

Timeline

• Start date: 2015-01-01
• Primary completion: 2015-12-31
• Completion: 2015-12-31
• First posted: 2015-06-09
• Last updated: 2017-01-26

Locations

1 site across 1 country: United States